Company · CIK 1840574

# Verve Therapeutics, Inc.

| CIK | [1840574](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840574) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-08-12 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-267578 | Shelf Effective | 2022-09-23 | 2025-07-28 | 5 |
| 333-265996 | Shelf Effective | 2022-07-01 | 2022-07-21 | 4 |
| 333-256608 | IPO Final prospectus | 2021-05-28 | 2021-06-17 | 4 |

## Filings

 14

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-07-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840574/999999999525002366/9999999995-25-002366-index.htm) Declared effective | 333-267578 | 9999999995-25-002366 |
| 2025-05-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840574/999999999525001576/9999999995-25-001576-index.htm) Declared effective | 333-267578 | 9999999995-25-001576 |
| 2023-11-29 | [424B5](https://www.sec.gov/Archives/edgar/data/1840574/000119312523285234/0001193125-23-285234-index.htm) Shelf takedown | 333-267578 | 0001193125-23-285234 |
| 2023-11-28 | [424B5](https://www.sec.gov/Archives/edgar/data/1840574/000119312523284309/0001193125-23-284309-index.htm) Shelf takedown | 333-267578 | 0001193125-23-284309 |
| 2022-09-23 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1840574/000119312522250139/0001193125-22-250139-index.htm) Shelf registered | 333-267578 | 0001193125-22-250139 |
| 2022-07-21 | [424B5](https://www.sec.gov/Archives/edgar/data/1840574/000119312522199221/0001193125-22-199221-index.htm) Shelf takedown | 333-265996 | 0001193125-22-199221 |
| 2022-07-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1840574/000119312522198120/0001193125-22-198120-index.htm) Shelf takedown | 333-265996 | 0001193125-22-198120 |
| 2022-07-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840574/999999999522002046/9999999995-22-002046-index.htm) Declared effective | 333-265996 | 9999999995-22-002046 |
| 2022-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1840574/000119312522187258/0001193125-22-187258-index.htm) Shelf registered | 333-265996 | 0001193125-22-187258 |
| 2021-06-17 | [424B4](https://www.sec.gov/Archives/edgar/data/1840574/000119312521193270/0001193125-21-193270-index.htm) Final prospectus | 333-256608 | 0001193125-21-193270 |
| 2021-06-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1840574/999999999521002372/9999999995-21-002372-index.htm) Declared effective | 333-256608 | 9999999995-21-002372 |
| 2021-06-14 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1840574/000119312521189442/0001193125-21-189442-index.htm) Amendment | 333-256608 | 0001193125-21-189442 |
| 2021-05-28 | [S-1](https://www.sec.gov/Archives/edgar/data/1840574/000119312521176910/0001193125-21-176910-index.htm) Registration filed | 333-256608 | 0001193125-21-176910 |
| 2021-04-16 | [DRS](https://www.sec.gov/Archives/edgar/data/1840574/000095012321004649/0000950123-21-004649-index.htm) Draft made public | 377-04675 | 0000950123-21-004649 |

[All filings of this company](https://equitycapital.markets/filings?cik=1840574) · [CSV](https://equitycapital.markets/filings.csv?cik=1840574)

---
Source page: https://equitycapital.markets/company/1840574 · Data: U.S. SEC EDGAR · CC BY 4.0